Suppr超能文献

透析治疗的肾衰竭患者 COVID-19 症状和结局的性别差异:一项前瞻性队列研究。

Sex differences in COVID-19 symptoms and outcomes in people with kidney failure treated with dialysis: a prospective cohort study.

机构信息

Department of Medicine, University of Calgary, Calgary, AB, Canada.

Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.

出版信息

J Nephrol. 2023 Apr;36(3):851-860. doi: 10.1007/s40620-022-01448-0. Epub 2022 Sep 10.

Abstract

BACKGROUND

People with kidney failure treated with dialysis are at increased risk of SARS-CoV-2 infection, and severe COVID-19 outcomes such as hospitalization and death. Though there are well-defined sex differences in outcomes for the general population with COVID-19, we do not know whether this translates into kidney failure populations. We aimed to estimate the differences in COVID-19 symptoms and clinical outcomes between males and females treated with maintenance dialysis.

METHODS

In this prospective observational cohort study, we included adults treated with maintenance dialysis in Southern Alberta, Canada that tested positive for COVID-19 between March 2020 and February 2022. We examined the association between sex (dichotomized as male and female) with COVID-19 symptoms including fever, cough, malaise, shortness of breath, muscle joints/aches, nausea and/or vomiting, loss of appetite, diarrhea, headache, sore throat, and loss of smell/taste using chi-square or Fisher's exact tests. Secondary outcomes included 30-day hospitalization, ICU admission, and death.

RESULTS

Of 1,329 cohort participants, 246 (18.5%) tested positive for SARS-CoV-2 and were included in our study, including 95 females (39%). Of 207 participants with symptoms assessed, females had less frequent fever (p = 0.003), and more nausea or vomiting (p = 0.003) compared to males, after correction for multiple testing. Males exhibited no symptoms 25% of the time, compared with 10% of females (p = 0.01, not significant when corrected for multiple testing). We did not identify statistically significant differences in clinical outcomes between the sexes, though vaccinated patients had lower odds of hospitalization.

CONCLUSIONS

Sex differences in COVID-19 symptoms were identified in a cohort of patients treated with maintenance dialysis, which may inform sex-specific screening strategies in dialysis units. Further work is necessary to examine mechanisms for identified sex differences.

摘要

背景

接受透析治疗的肾衰竭患者感染 SARS-CoV-2 的风险增加,并且 COVID-19 结局严重,如住院和死亡。尽管 COVID-19 普通人群的结局存在明确的性别差异,但我们尚不清楚这是否转化为肾衰竭人群。我们旨在评估接受维持性透析治疗的男性和女性 COVID-19 症状和临床结局的差异。

方法

在这项前瞻性观察队列研究中,我们纳入了 2020 年 3 月至 2022 年 2 月期间在加拿大艾伯塔省南部接受维持性透析治疗且 COVID-19 检测呈阳性的成年人。我们使用卡方检验或 Fisher 精确检验,研究了性别(分为男性和女性)与 COVID-19 症状(包括发热、咳嗽、不适、呼吸急促、肌肉关节/疼痛、恶心和/或呕吐、食欲不振、腹泻、头痛、喉咙痛和嗅觉/味觉丧失)之间的关联。次要结局包括 30 天住院、入住 ICU 和死亡。

结果

在 1329 名队列参与者中,有 246 名(18.5%) SARS-CoV-2 检测呈阳性,纳入了我们的研究,其中包括 95 名女性(39%)。在评估症状的 207 名参与者中,女性发热的频率较低(p=0.003),且比男性更易出现恶心或呕吐(p=0.003),但经过多次检验校正后差异无统计学意义。男性有 25%的时间无症状,而女性有 10%的时间无症状(p=0.01,未校正多次检验时无统计学意义)。我们未发现性别之间在临床结局方面存在统计学差异,但接种疫苗的患者住院的可能性较低。

结论

在接受维持性透析治疗的患者队列中,发现了 COVID-19 症状的性别差异,这可能为透析单位的特定性别筛查策略提供信息。需要进一步研究来检查确定的性别差异的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ad/9463668/04e3f199666a/40620_2022_1448_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验